The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Adipokines and inflammation: is it a question of weight?
Open accessAbstract
Obesity has reached epidemic proportions in the Western society and is increasing in the developing world. It is considered as one of the major contributors to the global burden of disability and chronic diseases, including autoimmune, inflammatory and degenerative diseases. Research conducted on obesity and its complications over the last two decades has transformed the outdated concept of white adipose tissue (WAT) merely serving as an energy depot. WAT is now recognized as an active and inflammatory organ capable of producing a wide variety of factors known as adipokines. These molecules participate through endocrine, paracrine, autocrine or juxtacrine crosstalk mechanisms in a great variety of physiological or pathophysiological processes, regulating food intake, insulin sensitivity, immunity and inflammation. Although initially restricted to metabolic activities (regulation of glucose and lipid metabolism), adipokines currently represent a new family of proteins that can be considered key players in the complex network of soluble mediators involved in the pathophysiology of immune/inflammatory diseases. However, the complexity of the adipokine network in the pathogenesis and progression of inflammatory diseases has posed, since the beginning, the important question of whether it may be possible to target the mechanism(s) by which adipokines contribute to disease selectively without suppressing their physiological functions. Here, we explore in depth the most recent findings concerning the involvement of adipokines in inflammation and immune responses, in particular in rheumatic, inflammatory and degenerative diseases. We also highlight several possible strategies for therapeutic development and propose that adipokines and their signalling pathways may represent innovative therapeutic strategies for inflammatory disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
European Guidelines for Obesity Management in Adults
Yumuk, V., Tsigos, C., Fried, M., Schindler, K., Busetto, L., Micic, D., & Toplak, H. (2015) · Obesity Facts · doi:10.1159/000442721 · Cited by 3,432
Lipocalin-2: A Master Mediator of Intestinal and Metabolic Inflammation
Moschen, A. R., Adolph, T. E., Gerner, R. R., Wieser, V., & Tilg, H. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2017.01.003 · Cited by 359
Interplay between the immune system and adipose tissue in obesity
Exley, M. A., Hand, L., O'Shea, D., & Lynch, L. (2014) · Journal of Endocrinology · doi:10.1530/joe-13-0516 · Cited by 242 · cited 4×
“…main resident T cell population, secreted anti-inflammatory cytokines (IL-10 and IL-4) that polarize adipose tissue macrophages towards an anti-inflammatory phenotype (i.e. M2 or alternatively activated macrophages), thus maintaining a tolerogenic environment (Exley et al., 2014; Huh et al., 2014).”
InfluentialDevelopment of second generation peptides modulating cellular adiponectin receptor responses
Otvos, L., Knappe, D., Hoffmann, R., Kovalszky, I., Olah, J., Hewitson, T. D., Stawikowska, R., Stawikowski, M., Cudic, P., Lin, F., et al. (2014) · Frontiers in Chemistry · doi:10.3389/fchem.2014.00093 · Cited by 50
Cited by
Pro-inflammatory cytokines: The link between obesity and osteoarthritis
Wang, T., & He, C. (2018) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2018.10.002 · Cited by 1,034
Metabolic barriers to cancer immunotherapy
DePeaux, K., & Delgoffe, G. M. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00541-y · Cited by 597
Obesity, Bioactive Lipids, and Adipose Tissue Inflammation in Insulin Resistance
Kojta, I., Chacińska, M., & Błachnio-Zabielska, A. (2020) · Nutrients · doi:10.3390/nu12051305 · Cited by 526
The role of adipokines in health and disease
Clemente-Suárez, V. J., Redondo-Flórez, L., Beltrán-Velasco, A. I., Martín-Rodríguez, A., Martínez-Guardado, I., Navarro-Jiménez, E., Laborde-Cárdenas, C. C., & Tornero-Aguilera, J. F. (2023) · Biomedicines · doi:10.3390/biomedicines11051290 · Cited by 463
A new immunometabolic perspective of intervertebral disc degeneration
Francisco, V., Pino, J., González-Gay, M. Á., Lago, F., Karppinen, J., Tervonen, O., Mobasheri, A., & Gualillo, O. (2022) · Nature Reviews Rheumatology · doi:10.1038/s41584-021-00713-z · Cited by 462
Self-citationFundamentals of osteoarthritis: Inflammatory mediators in osteoarthritis
De Roover, A., Escribano-Núñez, A., Monteagudo, S., & Lories, R. (2023) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2023.06.005 · Cited by 278
The Influence of Adipokines on Radiographic Damage in Inflammatory Rheumatic Diseases
Toussirot, E. (2023) · Biomedicines · doi:10.3390/biomedicines11020536 · Cited by 12
Metadata
- Authors
- Francisco, V., Pino, J., Gonzalez‐Gay, M. A., Mera, A., Lago, F., Gómez, R., Mobasheri, A., & Gualillo, O.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2018-04-10
- Volume
- 175
- Issue
- 10
- Pages
- 1569-1579
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2791057812
- Cited by
- 166
- References
- 4
- FWCI
- 15.34
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.